http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1139455-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_966a6c1f382ec9bcb5e3839dfd73e5b8
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D233-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D233-91
filingDate 1967-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1969-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1139455-A
titleOfInvention Novel imidazole derivatives and a process for the manufacture thereof
abstract 1,139,455. Imidazole derivatives. F. HOFFMANN-LA ROCHE & CO. A.G. 9 June, 1967 [10 June, 1966], No. 26766/67. Heading C2C. Novel compounds of the general formula wherein R<SP>1</SP> and R<SP>2</SP> each represent an optional C 1-7 alkyl group and Z represents a grouping of formula or, when at least one of R<SP>1</SP> and R<SP>2</SP> is present, a grouping of the formula or, when R<SP>1</SP> and R<SP>2</SP> are both absent, a grouping of the formula and pharmaceutically acceptable salts thereof: in which groupings R<SP>3</SP> represents a halogen atom or a hydroxyl, lower-alkoxy, lower-alkenyloxy, lower-alkynyloxy, halo - (lower-alkoxy), polyhalo-(lower-alkoxy) or halo-(lower-alkynyloxy) group or a phenoxy group which may carry one or more halo, lower-alkyl or lower-alkoxy substituents, Ac represents a lower-alkanoyl group or a benzoyl group which may carry one or more halo, lower-alkyl or lower-alkoxy substituents, R<SP>4</SP> represents a lower-alkanoyl group, R<SP>30</SP> represents a lower-alkenyloxy, lower-alkynyloxy, halo-(lower-alkoxy), polyhalo-(lower-alkoxy) or halo-(lower-alkynyloxy) group or a phenoxy group which may carry one or more halo, lower-alkyl or lower-alkoxy substituents and Ac<SP>1</SP> represents a benzoyl group which may carry one or more halo, lower-alkyl or loweralkoxy substituents, are prepared by reacting a 2-nitro-imidazol with a compound of the general formula and, if desired, converting the resulting alcohol into its alkanoic acid ester, or by reacting a compound of the general formula wherein of R<SP>1</SP> and R<SP>2</SP> at least one is present with a compound of the formula to form an alcohol of the above formula and, if desired, acylating the said alcohol to give an ester of the above formula or oxidizing the said alcohol formed with a chromate solution to form a ketone of the above formula or treating an alcohol in which R 3 is present and represents the halogen with a base to form a compound containing the epoxide grouping, or by reacting an imidazole of the last general formula above with a halo-acetone to form a ketone of the first general formula above, or reacting a ketone with semicarbazide or a salt thereof to form a semicarbazone of the first formula above and, in any case, converting, if desired, the product into a pharmaceutically acceptable salt thereof. 1,2 - Epoxy - 3 - [3 - iodo - propyn - (2) - yloxy]. propane is prepared from 3-iodopropargyl alcohol and epichlorohydrin. Pharmaceutical compositions having antimicrobial activity and in conventional form for oral, rectal, parenteral or topical application, comprise an above novel compound and one or more carriers or diluents therefor.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0093963-A1
priorityDate 1966-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24461
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458394823
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6334
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5196
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419537701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID180
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457582482
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556968
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419584339
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419543317
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7835
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520497
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419546850

Total number of triples: 30.